Aldevron Breakthrough Blog

Webinar On Demand: Revolutionizing mRNA Manufacturing

April 2, 2025 by Aldevron

Introducing AlchemyTM Cell-free DNA Technology

Time. It’s an overriding element therapeutics developers and manufacturers face in the production process. Enter Aldevron’s new Alchemy™ Cell-free DNA technology. In an Outsourced Pharma Capacity Update (OPCU) webinar, Nate Russart, PhD, and Tanner Dockendorf discussed the advantages of Alchemy, a next-generation solution for rapid production of linear DNA template for mRNA manufacturing. This innovative synthetic technology can cut production timelines by over 50%.

In this presentation, Russart and Dockendorf show how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA pipeline. The key highlights of the discussion on Alchemy’s advantages include:

This presentation is available on demand for you to learn more about Alchemy and what it might offer you as we move into the future of mRNA production and offer the means to transform your manufacturing processes.

Watch the webinar on-demand

Subscribe to our blog

ABOUT THE AUTHOR

Aldevron

Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from research grade to clinical trials to commercial applications. Aldevron specializes in cGMP manufacturing and is known for inventing the GMP-Source® quality system. Aldevron operates the largest cGMP plasmid DNA manufacturing facility in the world at company headquarters in Fargo, North Dakota, with additional facilities in Madison, Wisconsin.